[Meta-analysis on acute pain. Rofecoxib helped three quarters of patients].
D000208:Acute Disease; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D003627:Data Interpretation, Statistical; D004311:Double-Blind Method; D006801:Humans; D007783:Lactones / Q000008:administration & dosage / Q000627:therapeutic use*; D015201:Meta-Analysis as Topic; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D013450:Sulfones; D013997:Time Factors; D014081:Tooth Extraction / Q000009:adverse effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D010919:Placebos; D013450:Sulfones; C116926:rofecoxib